Scientific Programme

Preliminary Programme

Monday, 6th April 2020

07:45-08:50

Registration 

08:50-09:00

Opening Welcome
Conference Chairs  

09:00-10:30

Session I: The Journey from GWAS to the Clinic

09:00-09:30

Genomewide Perspectives of Multiple Sclerosis
Stephen Sawcer, UK

09:30-10:00

Genetics of Neuroinflammatory Diseases
Ingrid Kockum, Sweden

10:00-10:30

Stratifying Genetic Risk in Multiple Sclerosis Reveals Discrete Immune Cell Subsets
Kate Attfield, UK

10:30-11:00

Coffee Break, Poster Viewing and Exhibition Visit

11:00-12:30

Session II: Same Questions, New Answers

11:00-11:30

Dissecting Multiple Sclerosis at The Single Cell Level
Hayley Evans, UK

11:30-12:00

Breaking (Bad) Brain Barrier Beliefs
Jonathan Kipnis, USA

12:00-12:30

The Monocyte-To-Macrophage Transition in Chronic Brain Inflammation
Burkhard Becher, Switzerland

12:30-13:30

Lunch Break, Poster Viewing and Exhibition Visit

13:30-15:00

Session III:  Outside - In: How the Environment Shapes our CNS

13:30-14:00

The Brain Barriers Regulate CNS Immune Privilege
Britta Engelhardt, Switzerland

14:00-14:30

How the Gut Shapes the CNS Immune System
Marco Prinz, Germany

14:30-15:00

Learning from Viruses: Neuroimmune Mechanisms of Cognitive Dysfunction
Robyn S Klein, USA

15:00-15:30

 Coffee Break, Poster Viewing and Exhibition Visit

15:30-17:00

Session IV:  In Vivo Modelling of Disease

15:30-16:00

Lymphocyte Trafficking to The CNS – Does Provenance Matter?
Thomas Korn, Germany

16:00-16:30

Role of Microglia in The Remyelination of the CNS
Mikael Simons, Germany

16:30-17:00

How CD8 T Cells Shape CNS Autoimmune Disease
Joan M Goverman, USA




Tuesday, 7th April 2020

08:00-09:00

Registration 

09:00-10:30

Session V: Dementia: Understanding Neurodegeneration

09:00-09:30

Does Innate Immunity Contribute to Neurodegenerative Disease?
Michael T Heneka, Germany

09:30-10:00

GLP-1 and Dementia
Lotte Bjerre Knudsen, Denmark

10:00-10:30

Deriving Cellular Communities of The CNS Parenchyma and Understanding Their Relation to Alzheimer’s Disease and Multiple Sclerosis
Philip L De Jager, USA

10:30-11:00

Coffee Break, Poster Viewing and Exhibition Visit

11:00-12:00

Session VI: Dissecting Heterogenous Diseases: MS and NMO

11:00-11:30

What can we learn about Multiple Sclerosis from MOG and AQP4-Ab disease?
Jacqueline Palace, UK

11:30-12:00

Treatment of NMO
Friedemann Paul, Germany

12:00-13:00

Lunch Break, Poster Viewing and Exhibition Visit

13:00-14:00

Session VII: Recent Advances in CNS Imaging

13:00-13:30

Recent advances in MRI in Multiple Sclerosis
Olga Ciccarelli, UK

13:30-14:00

Pathological Insights into Progressive Multiple Sclerosis
Gabriele De Luca, UK

14:00-14:30

 Coffee Break, Poster Viewing and Exhibition Visit

14:30-16:15

Session VIII: Treatments for CNS Diseases – Where Do We Go Now?

14:30-15:00

Modulating Neuronal Resilience in Multiple Sclerosis
Manuel Friese, Germany

15:00-15:30

Is Immune Resetting for Treatment of Multiple Sclerosis Achievable?
Paolo Muraro, UK

15:30-16:00

The Way Forward in Neuroinflammation
Lars Fugger, UK

16:00-16:05

Best Abstract Award  

Closing remarks